|Bid||51.49 x 39400|
|Ask||51.92 x 1400|
|Day's Range||51.55 - 51.76|
|52 Week Range||44.06 - 55.70|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||0.98|
|Expense Ratio (net)||0.09%|
More Action: US-China Trade Talks Resume Next Week(Continued from Prior Part)US-China talks In the previous part, we discussed that the US (QQQ) and China plan to resume the trade talks next week. So far, China’s economic data have disappointed
Economic Slowdown Deepens, Central Banks Take Charge(Continued from Prior Part)Central banks As we discussed previously, central banks in developed economies like the US (SPY), Europe (VGK) (VEU), and Japan (EWJ) have adopted a dovish approach. While
Among the emerging market (VEU) currencies, the Argentinian peso, Turkish (TUR) lira, Indonesia rupiah, and Indian rupee are declining to all-time lows. The US dollar is also strengthening against all major currencies, including those of emerging markets. As the US dollar strengthens and interest rates rise, the cost of servicing US debt for other countries goes up.
A few countries have been spared in the global massacre and will likely maintain their strength. As such, we have highlighted those country ETFs that delivered near to double-digit returns in the first half.
GlaxoSmithKline’s (GSK) Consumer Healthcare segment includes various products for oral health, wellness, nutrition, and skin health. The Consumer Healthcare segment reported a 3% fall in its YoY (year-over-year) revenue to ~2.0 billion pounds in Q1 2018 compared to Q1 2017.